2023-02-132024-02-282024-02-28false14657118Seven Pines Dental Ltd2024-12-17falseiso4217:GBPxbrli:pure146571182023-02-13146571182024-02-28146571182023-02-132024-02-28146571182023-02-12146571182023-02-12146571182023-02-122023-02-1214657118bus:SmallEntities2023-02-132024-02-2814657118bus:AuditExempt-NoAccountantsReport2023-02-132024-02-2814657118bus:FullAccounts2023-02-132024-02-2814657118bus:PrivateLimitedCompanyLtd2023-02-132024-02-2814657118core:WithinOneYear2024-02-2814657118core:AfterOneYear2024-02-2814657118core:WithinOneYear2023-02-1214657118core:AfterOneYear2023-02-1214657118core:ShareCapital2024-02-2814657118core:SharePremium2024-02-2814657118core:RevaluationReserve2024-02-2814657118core:OtherReservesSubtotal2024-02-2814657118core:RetainedEarningsAccumulatedLosses2024-02-2814657118core:ShareCapital2023-02-1214657118core:SharePremium2023-02-1214657118core:RevaluationReserve2023-02-1214657118core:OtherReservesSubtotal2023-02-1214657118core:RetainedEarningsAccumulatedLosses2023-02-1214657118core:LandBuildings2024-02-2814657118core:PlantMachinery2024-02-2814657118core:Vehicles2024-02-2814657118core:FurnitureFittings2024-02-2814657118core:OfficeEquipment2024-02-2814657118core:NetGoodwill2024-02-2814657118core:IntangibleAssetsOtherThanGoodwill2024-02-2814657118core:ListedExchangeTraded2024-02-2814657118core:UnlistedNon-exchangeTraded2024-02-2814657118core:LandBuildings2023-02-1214657118core:PlantMachinery2023-02-1214657118core:Vehicles2023-02-1214657118core:FurnitureFittings2023-02-1214657118core:OfficeEquipment2023-02-1214657118core:NetGoodwill2023-02-1214657118core:IntangibleAssetsOtherThanGoodwill2023-02-1214657118core:ListedExchangeTraded2023-02-1214657118core:UnlistedNon-exchangeTraded2023-02-1214657118core:LandBuildings2023-02-132024-02-2814657118core:PlantMachinery2023-02-132024-02-2814657118core:Vehicles2023-02-132024-02-2814657118core:FurnitureFittings2023-02-132024-02-2814657118core:OfficeEquipment2023-02-132024-02-2814657118core:NetGoodwill2023-02-132024-02-2814657118core:IntangibleAssetsOtherThanGoodwill2023-02-132024-02-2814657118core:ListedExchangeTraded2023-02-132024-02-2814657118core:UnlistedNon-exchangeTraded2023-02-132024-02-2814657118core:MoreThanFiveYears2023-02-132024-02-2814657118core:Non-currentFinancialInstruments2024-02-2814657118core:Non-currentFinancialInstruments2023-02-1214657118dpl:CostSales2023-02-132024-02-2814657118dpl:DistributionCosts2023-02-132024-02-2814657118core:LandBuildings2023-02-132024-02-2814657118core:PlantMachinery2023-02-132024-02-2814657118core:Vehicles2023-02-132024-02-2814657118core:FurnitureFittings2023-02-132024-02-2814657118core:OfficeEquipment2023-02-132024-02-2814657118dpl:AdministrativeExpenses2023-02-132024-02-2814657118core:NetGoodwill2023-02-132024-02-2814657118core:IntangibleAssetsOtherThanGoodwill2023-02-132024-02-2814657118dpl:GroupUndertakings2023-02-132024-02-2814657118dpl:ParticipatingInterests2023-02-132024-02-2814657118dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-132024-02-2814657118core:ListedExchangeTraded2023-02-132024-02-2814657118dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-132024-02-2814657118core:UnlistedNon-exchangeTraded2023-02-132024-02-2814657118dpl:CostSales2023-02-122023-02-1214657118dpl:DistributionCosts2023-02-122023-02-1214657118core:LandBuildings2023-02-122023-02-1214657118core:PlantMachinery2023-02-122023-02-1214657118core:Vehicles2023-02-122023-02-1214657118core:FurnitureFittings2023-02-122023-02-1214657118core:OfficeEquipment2023-02-122023-02-1214657118dpl:AdministrativeExpenses2023-02-122023-02-1214657118core:NetGoodwill2023-02-122023-02-1214657118core:IntangibleAssetsOtherThanGoodwill2023-02-122023-02-1214657118dpl:GroupUndertakings2023-02-122023-02-1214657118dpl:ParticipatingInterests2023-02-122023-02-1214657118dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-122023-02-1214657118core:ListedExchangeTraded2023-02-122023-02-1214657118dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-122023-02-1214657118core:UnlistedNon-exchangeTraded2023-02-122023-02-1214657118core:NetGoodwill2024-02-2814657118core:IntangibleAssetsOtherThanGoodwill2024-02-2814657118core:LandBuildings2024-02-2814657118core:PlantMachinery2024-02-2814657118core:Vehicles2024-02-2814657118core:FurnitureFittings2024-02-2814657118core:OfficeEquipment2024-02-2814657118core:AfterOneYear2024-02-2814657118core:WithinOneYear2024-02-2814657118core:ListedExchangeTraded2024-02-2814657118core:UnlistedNon-exchangeTraded2024-02-2814657118core:ShareCapital2024-02-2814657118core:SharePremium2024-02-2814657118core:RevaluationReserve2024-02-2814657118core:OtherReservesSubtotal2024-02-2814657118core:RetainedEarningsAccumulatedLosses2024-02-2814657118core:NetGoodwill2023-02-1214657118core:IntangibleAssetsOtherThanGoodwill2023-02-1214657118core:LandBuildings2023-02-1214657118core:PlantMachinery2023-02-1214657118core:Vehicles2023-02-1214657118core:FurnitureFittings2023-02-1214657118core:OfficeEquipment2023-02-1214657118core:AfterOneYear2023-02-1214657118core:WithinOneYear2023-02-1214657118core:ListedExchangeTraded2023-02-1214657118core:UnlistedNon-exchangeTraded2023-02-1214657118core:ShareCapital2023-02-1214657118core:SharePremium2023-02-1214657118core:RevaluationReserve2023-02-1214657118core:OtherReservesSubtotal2023-02-1214657118core:RetainedEarningsAccumulatedLosses2023-02-1214657118core:NetGoodwill2023-02-1214657118core:IntangibleAssetsOtherThanGoodwill2023-02-1214657118core:LandBuildings2023-02-1214657118core:PlantMachinery2023-02-1214657118core:Vehicles2023-02-1214657118core:FurnitureFittings2023-02-1214657118core:OfficeEquipment2023-02-1214657118core:AfterOneYear2023-02-1214657118core:WithinOneYear2023-02-1214657118core:ListedExchangeTraded2023-02-1214657118core:UnlistedNon-exchangeTraded2023-02-1214657118core:ShareCapital2023-02-1214657118core:SharePremium2023-02-1214657118core:RevaluationReserve2023-02-1214657118core:OtherReservesSubtotal2023-02-1214657118core:RetainedEarningsAccumulatedLosses2023-02-1214657118core:AfterOneYear2023-02-132024-02-2814657118core:WithinOneYear2023-02-132024-02-2814657118core:Non-currentFinancialInstrumentscore:CostValuation2023-02-132024-02-2814657118core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-132024-02-2814657118core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-132024-02-2814657118core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-132024-02-2814657118core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-132024-02-2814657118core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-132024-02-2814657118core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-132024-02-2814657118core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-132024-02-2814657118core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-132024-02-2814657118core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2814657118core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2814657118core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2814657118core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2814657118core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2814657118core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2814657118core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2814657118core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2814657118core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2814657118core:Non-currentFinancialInstrumentscore:CostValuation2023-02-1214657118core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-1214657118core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-1214657118core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-1214657118core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-1214657118core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-1214657118core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-1214657118core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-1214657118core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-1214657118bus:Director12023-02-132024-02-2814657118bus:Director22023-02-132024-02-28

Seven Pines Dental Ltd

Registered Number
14657118
(England and Wales)

Unaudited Financial Statements for the Period ended
28 February 2024

Seven Pines Dental Ltd
Company Information
for the period from 13 February 2023 to 28 February 2024

Directors

Mrs Nadine Boojawon
Dr Ravi Boojawon

Registered Address

Fulford Lodge 1 Heslington Lane
Fulford
York
YO10 4HW

Registered Number

14657118 (England and Wales)
Seven Pines Dental Ltd
Statement of Financial Position
28 February 2024

Notes

2024

£

£

Fixed assets
Tangible assets33,330
3,330
Current assets
Debtors49,961
Cash at bank and on hand14,852
24,813
Creditors amounts falling due within one year5(7,679)
Net current assets (liabilities)17,134
Total assets less current liabilities20,464
Net assets20,464
Capital and reserves
Profit and loss account20,464
Shareholders' funds20,464
The financial statements were approved and authorised for issue by the Board of Directors on 17 December 2024, and are signed on its behalf by:
Dr Ravi Boojawon
Director
Registered Company No. 14657118
Seven Pines Dental Ltd
Notes to the Financial Statements
for the period ended 28 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The financial statements have been prepared on the historical cost basis.
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Current taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Plant and machinery20
Office Equipment20
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

2024
Average number of employees during the year2
3.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
Additions1,0153,1484,163
At 28 February 241,0153,1484,163
Depreciation and impairment
Charge for year203630833
At 28 February 24203630833
Net book value
At 28 February 248122,5183,330
At 12 February 23---
4.Debtors: amounts due within one year

2024

£
Trade debtors / trade receivables9,961
Total9,961
5.Creditors: amounts due within one year

2024

£
Taxation and social security6,376
Other creditors1,054
Accrued liabilities and deferred income249
Total7,679
6.Related party transactions
At the year end the Directors Loan Account stood at a credit balance of £1,054. Interest was charged on the loan at the UK market rate on a monthly basis. This loan is repayable upon demand.